OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Showing 9 citing articles:
A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
Nagisa Tokunoh, Shigeyuki Tamiya, Masato Watanabe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Nagisa Tokunoh, Shigeyuki Tamiya, Masato Watanabe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 10
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 10
Safety, immunogenicity, and protective effective of inhaled COVID‐19 vaccines: A systematic review and meta‐analysis
Song Gao, Rong Li, Meng-Qun Cheng
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 3
Song Gao, Rong Li, Meng-Qun Cheng
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access | Times Cited: 3
Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial
Chun Keat Chew, Ruijie Wang, Sunita Bavanandan, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Chun Keat Chew, Ruijie Wang, Sunita Bavanandan, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals
Najwa D. Aljehani, Levi Tamming, Muhammad Yasir Khan, et al.
mBio (2024)
Closed Access | Times Cited: 1
Najwa D. Aljehani, Levi Tamming, Muhammad Yasir Khan, et al.
mBio (2024)
Closed Access | Times Cited: 1
Exploring the potential benefits of mucosal COVID-19 vaccines: opportunities and challenges
Júlio Croda
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1099-1100
Open Access | Times Cited: 3
Júlio Croda
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1099-1100
Open Access | Times Cited: 3
A next-generation inhalable dry powder COVID vaccine
Zhou Xing, Mangalakumari Jeyanathan
Nature (2023) Vol. 624, Iss. 7992, pp. 532-534
Closed Access | Times Cited: 3
Zhou Xing, Mangalakumari Jeyanathan
Nature (2023) Vol. 624, Iss. 7992, pp. 532-534
Closed Access | Times Cited: 3
LPS-induced lung tissue-resident trained innate immunity provides differential protection against pneumococci and SARS-CoV-2
Alisha Kang, Gluke Ye, Sam Afkhami, et al.
Cell Reports (2024) Vol. 43, Iss. 10, pp. 114849-114849
Open Access
Alisha Kang, Gluke Ye, Sam Afkhami, et al.
Cell Reports (2024) Vol. 43, Iss. 10, pp. 114849-114849
Open Access
Factors associated with SARS-CoV-2 symptomatic infection in university students: a school-wide web-based survey during the Omicron variant outbreak
Mai Katahira, Hisami Sameshima, Rie Tanuma, et al.
Authorea (Authorea) (2023)
Open Access
Mai Katahira, Hisami Sameshima, Rie Tanuma, et al.
Authorea (Authorea) (2023)
Open Access
